Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Claire Gourzones"'
Autor:
Claude Saegerman, Anh Nguyet Diep, Véronique Renault, Anne-Françoise Donneau, Lambert Stamatakis, Wouter Coppieters, Fabienne Michel, Christophe Breuer, Margaux Dandoy, Olivier Ek, Claire Gourzones, Joey Schyns, Emeline Goffin, Frédéric Minner, Keith Durkin, Maria Artesi, Vincent Bours, Fabrice Bureau, Laurent Gillet
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-11 (2022)
Saegerman et al. perform saliva SARS-CoV-2 testing in a cohort of nursing home workers in Belgium who are either unvaccinated or have received one or two doses of the BNT162b2 mRNA vaccine. The authors show that vaccination protects against shedding
Externí odkaz:
https://doaj.org/article/463250a6d8824418b5de22beedc95631
Autor:
Hugues de Boussac, Angélique Bruyer, Michel Jourdan, Anke Maes, Nicolas Robert, Claire Gourzones, Laure Vincent, Anja Seckinger, Guillaume Cartron, Dirk Hose, Elke De Bruyne, Alboukadel Kassambara, Philippe Pasero, Jérôme Moreaux
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
Multiple myeloma (MM) account for approximately 10% of hematological malignancies and is the second most common hematological disorder. Kinases inhibitors are widely used and their efficiency for the treatment of cancers has been demonstrated. Here,
Externí odkaz:
https://doaj.org/article/a98ff82fb4d94f1094f15874d93909af
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Multiple myeloma (MM) is a malignancy characterized by accumulation of malignant plasma cells within the bone marrow (BM). MM is considered mostly without definitive treatment because of the inability of standard of care therapies to overcome drug-re
Externí odkaz:
https://doaj.org/article/718ed61c7fd24747b9a8263e5d74a09b
Autor:
Fabrice Bureau, Wouter Coppieters, Laurent Gillet, Lambert Stamatakis, Claire Gourzones, Christophe Breuer, Olivier Ek, Niko Speybroeck, Fabienne Michel, Emeline Goffin, Anne-Françoise Donneau, Véronique Renault, Anh Nguyet Diep, Claude Saegerman, Alexandria Williams, Margaux Dandoy, Frédéric Minner, Joey Schyns
Publikováno v:
Transboundary and Emerging Diseases
Nursing home (NH) residents and staff have been severely affected by the COVID‐19 pandemic. The aim of this study was to examine the use of weekly saliva RT‐qPCR testing for SARS‐CoV‐2 detection among NH workers as a strategy to control disea
Autor:
Jérôme Moreaux, Claire Gourzones, Nicolas Robert, Anke Maes, Michel Jourdan, Philippe Pasero, Elke De Bruyne, Guillaume Cartron, Angelique Bruyer, Anja Seckinger, Alboukadel Kassambara, Laure Vincent, Dirk Hose, Hugues de Boussac
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, 105 (3), pp.784-795. ⟨10.3324/haematol.2018.208306⟩
Haematologica, 2020, 105 (3), pp.784-795. ⟨10.3324/haematol.2018.208306⟩
Haematologica, Ferrata Storti Foundation, 2020, 105 (3), pp.784-795. ⟨10.3324/haematol.2018.208306⟩
Haematologica, 2020, 105 (3), pp.784-795. ⟨10.3324/haematol.2018.208306⟩
International audience; Multiple myeloma (MM) account for approximately 10% of hematological malignancies and is the second most common hematological disorder. Kinases inhibitors are widely used and their efficiency for the treatment of cancers has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333afa9bceab97e7b1dfefd103f88204
https://hal.umontpellier.fr/hal-02587620
https://hal.umontpellier.fr/hal-02587620
Autor:
Laure Vincent, Angelique Bruyer, Hugues de Boussac, Nicolas Robert, Alboukadel Kassambara, Jérôme Moreaux, Djamila Chemlal, Guilhem Requirand, Amelie Machura, Claire Gourzones, Charles Herbaux
Publikováno v:
Blood. 138:2651-2651
Multiple myeloma (MM) is the second most common hematological malignancy characterized by an abnormal clonal proliferation of malignant plasma cells. Despite the introduction of novels agents that have significantly improved clinical outcomes, MM pat
Autor:
Eric Julien, Jian Jin, Claire Gourzones, Fanny Izard, Laurie Herviou, Celine Bellanger, Elke De Bruyne, Karin Vanderkerken, Guillaume Cartron, Charlotte Grimaud, Ouissem Karmous-Gadacha, Anqi Ma, Laure Vincent, Jérôme Moreaux, Eva Desmedt
Publikováno v:
Clinical Epigenetics
Clinical Epigenetics, BioMed Central, 2021, 13 (1), ⟨10.1186/s13148-021-01160-z⟩
BioRxiv
BioRxiv, In press, ⟨10.1101/776930⟩
Clinical Epigenetics, 2021, 13 (1), ⟨10.1186/s13148-021-01160-z⟩
Clinical Epigenetics, BioMed Central, 2021, 13 (1), ⟨10.1186/s13148-021-01160-z⟩
BioRxiv
BioRxiv, In press, ⟨10.1101/776930⟩
Clinical Epigenetics, 2021, 13 (1), ⟨10.1186/s13148-021-01160-z⟩
Background Multiple myeloma (MM) is a malignancy of plasma cells that largely remains incurable. The search for new therapeutic targets is therefore essential. In addition to a wide panel of genetic mutations, epigenetic alterations also appear as im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c091bc5491bdcecafba2c967100f616d
https://doi.org/10.1101/776930
https://doi.org/10.1101/776930
Autor:
Guillaume Cartron, Ouissem Karmous Gadacha, Sylvain Lamure, Laure Vincent, Claire Gourzones, Céline Bellanger, Jérôme Moreaux, Elvira Garcia de Paco, Bernard Klein
Publikováno v:
Cancers
Cancers, MDPI, 2019, 11 (4), pp.439. ⟨10.3390/cancers11040439⟩
Cancers, Vol 11, Iss 4, p 439 (2019)
Volume 11
Issue 4
Cancers, MDPI, 2019, 11 (4), pp.439. ⟨10.3390/cancers11040439⟩
Cancers, Vol 11, Iss 4, p 439 (2019)
Volume 11
Issue 4
Background: Multiple myeloma (MM) is the second most common hematological cancer after lymphoma. It is characterized by the accumulation of clonal malignant plasma cells within the bone marrow. The development of drug resistance remains a major probl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec761f730e0079802aedb851a517045
https://hal.umontpellier.fr/hal-02870153/document
https://hal.umontpellier.fr/hal-02870153/document
Autor:
Laure Vincent, Jérôme Moreaux, Dirk Hose, Grandmougin C, Christophe Hirtz, Philippe Pasero, Claire Gourzones, Viziteu E, Angelique Bruyer, Laurent Tiers, Yea-Lih Lin, Angelos Constantinou, H. Goldschmidt, Jihane Basbous, Bernard Klein, Anja Seckinger
Publikováno v:
Leukemia
Leukemia, 2017, 31 (10), pp.2104-2113. ⟨10.1038/leu.2017.54⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (10), pp.2104-2113. ⟨10.1038/leu.2017.54⟩
Europe PubMed Central
Leukemia, 2017, 31 (10), pp.2104-2113. ⟨10.1038/leu.2017.54⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (10), pp.2104-2113. ⟨10.1038/leu.2017.54⟩
Europe PubMed Central
International audience; Multiple myeloma (MM) is a plasma cell cancer with poor survival, characterized by the expansion of multiple myeloma cells (MMCs) in the bone marrow. Using a microarray-based genome-wide screen for genes responding to DNA meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de98832a2e071c24ee879ce0e8fa0c0
https://hal.science/hal-01630891
https://hal.science/hal-01630891
Publikováno v:
Oncologie. 10:722-727
Du point de vue biologique, la caracteristique majeure des CAPI consiste en un desequilibre entre la croissance des metastases et l’inhibition relative ou absolue de la croissance de la tumeur primitive. Des travaux recents ont mis en evidence une